Clinical Trial Update: Oxaliplatin, Capecitabine, and Cetuximab in Treating Patients With Advanced Liver Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating oxaliplatin, capecitabine, and cetuximab for advanced liver cancer (hepatocellular carcinoma) has completed. Results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• ERBITUX (cetuximab)
• Eloxatin (oxaliplatin)
• Xeloda (capecitabine)

Snippet

Sponsor: UNC Lineberger Comprehensive Cancer Center | Conditions: Liver Cancer | Phase 2 | Status: COMPLETED | Results posted: 2017-05-09